{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:12:26Z","timestamp":1790622746755,"version":"4.1.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ijdp.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.drugpo.2017.06.005","type":"journal-article","created":{"date-parts":[[2017,7,4]],"date-time":"2017-07-04T23:16:11Z","timestamp":1499210171000},"page":"172-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":241,"special_numbering":"C","title":["Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic"],"prefix":"10.1016","volume":"46","author":[{"given":"Nadia","family":"Fairbairn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip O.","family":"Coffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Y.","family":"Walley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.drugpo.2017.06.005_bib0005","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1111\/j.1526-4637.2011.01128.x","article-title":"Project Lazarus: Community-based overdose prevention in rural North Carolina","volume":"12","author":"Albert","year":"2011","journal-title":"Pain Medicine"},{"key":"10.1016\/j.drugpo.2017.06.005_bib0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12954-015-0088-4","article-title":"Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, Canada","volume":"12","author":"Amlani","year":"2015","journal-title":"Harm Reduction Journal"},{"issue":"10","key":"10.1016\/j.drugpo.2017.06.005_bib0015","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1001\/jamainternmed.2016.4306","article-title":"Adverse effects from counterfeit alprazolam tablets","volume":"176","author":"Arens","year":"2016","journal-title":"JAMA Internal Medicine"},{"issue":"1","key":"10.1016\/j.drugpo.2017.06.005_bib0020","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.annemergmed.2016.06.014","article-title":"Fentanyl and a novel synthetic opioid U-47700 masquerading as Street Norco in Central California: A case report","volume":"69","author":"Armenian","year":"2017","journal-title":"Annals of Emergency Medicine"},{"key":"10.1016\/j.drugpo.2017.06.005_bib0025","unstructured":"Beacon Dispatch Community-based overdose response. (2017)."},{"issue":"3","key":"10.1016\/j.drugpo.2017.06.005_bib0030","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11606-016-3911-z","article-title":"Acceptability of naloxone co-prescription among primary care providers treating patients on long-term opioid therapy for pain","volume":"32","author":"Behar","year":"2016","journal-title":"Journal of General Internal Medicine"},{"issue":"5","key":"10.1016\/j.drugpo.2017.06.005_bib0035","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/add.13265","article-title":"Effectiveness of Scotland's National Naloxone Programme for reducing opioid-related deaths: A before (2006\u20132010) versus after (2011\u20132013) comparison","volume":"111","author":"Bird","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2017.06.005_bib0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drugalcdep.2016.03.018","article-title":"A pilot randomized clinical trial of an intervention to reduce overdose risk behaviors among emergency department patients at risk for prescription opioid overdose","volume":"163","author":"Bohnert","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2017.06.005_bib0045","first-page":"2003","article-title":"Trends in naloxone prescriptions prescribed after implementation of a National Academic Detailing Service in the Veterans Health Administration: A preliminary analysis","author":"Bounthavong","year":"2017","journal-title":"Journal of the American Pharmaceutical Association"},{"key":"10.1016\/j.drugpo.2017.06.005_bib0050","series-title":"The consumers union report on licit and illicit drugs","author":"Brecher","year":"1972"},{"issue":"2","key":"10.1016\/j.drugpo.2017.06.005_bib0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/00952990.2015.1109648","article-title":"Legal regimes surrounding naloxone access: Considerations for prescribers","volume":"42","author":"Brodrick","year":"2016","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.drugpo.2017.06.005_bib0060","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/dta.1954","article-title":"Drug testing in Europe: Monitoring results of the Trans European Drug Information (TEDI) project","volume":"9","author":"Brunt","year":"2017","journal-title":"Drug Testing and Analysis"},{"issue":"5","key":"10.1016\/j.drugpo.2017.06.005_bib0065","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3109\/15563650.2016.1157722","article-title":"Could chest wall rigidity be a factor in rapid death from illicit fentanyl abuse?","volume":"54","author":"Burns","year":"2016","journal-title":"Clinical Toxicology (Philadelphia)"},{"key":"10.1016\/j.drugpo.2017.06.005_bib0070","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.drugpo.2016.04.017","article-title":"Results of an international drug testing service for cryptomarket users","volume":"35","author":"Caudevilla","year":"2016","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2017.06.005_bib0075","series-title":"Influx of fentanyl-laced counterfeit pills and toxic fentanyl-related compounds further increases risk of fentanyl-related overdose and fatalities","author":"CDC","year":"2016"},{"issue":"29","key":"10.1016\/j.drugpo.2017.06.005_bib0080","first-page":"793","article-title":"Nonpharmaceutical fentanyl-related deaths\u2013multiple states, April 2005\u2013March 2007","volume":"57","author":"Centers for Disease C & Prevention","year":"2008","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"43","key":"10.1016\/j.drugpo.2017.06.005_bib0085","first-page":"1487","article-title":"Vital signs: overdoses of prescription opioid pain relievers\u2013United States, 1999\u20132008","volume":"60","author":"Centers for Disease C & Prevention","year":"2011","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.drugpo.2017.06.005_bib0090","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.drugpo.2017.06.004","article-title":"Heroin uncertainties: Heroin uncertainties: Exploring users' perceptions of fentanyl-adulterated and\u2014substituted \u2018heroin","volume":"46","author":"Ciccarone","year":"2017","journal-title":"International Journal of Drug Policy"},{"issue":"2","key":"10.1016\/j.drugpo.2017.06.005_bib0095","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1056\/NEJMc1204141","article-title":"Effect of abuse-deterrent formulation of OxyContin","volume":"367","author":"Cicero","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.drugpo.2017.06.005_bib0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/ADM.0000000000000034","article-title":"A systematic review of community opioid overdose prevention and naloxone distribution programs","volume":"8","author":"Clark","year":"2014","journal-title":"Journal of Addiction Medicine"},{"issue":"4","key":"10.1016\/j.drugpo.2017.06.005_bib0105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7326\/M15-2771","article-title":"Nonrandomized intervention study of naloxone coprescription for primary care patients receiving long-term opioid therapy for pain","volume":"165","author":"Coffin","year":"2016","journal-title":"Annals of Internal Medicine"},{"issue":"7","key":"10.1016\/j.drugpo.2017.06.005_bib0110","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1553-2712.2007.tb01846.x","article-title":"Identifying injection drug users at risk of nonfatal overdose","volume":"14","author":"Coffin","year":"2007","journal-title":"Academic Emergency Medicine"},{"key":"10.1016\/j.drugpo.2017.06.005_bib0115","article-title":"\u2018Crisis' and \u2018everyday\u2019 initiators: A qualitative study of coercion and agency in the context of methadone maintenance treatment initiation","author":"Damon","year":"2016","journal-title":"Drug & Alcohol Review"},{"issue":"11","key":"10.1016\/j.drugpo.2017.06.005_bib0120","doi-asserted-by":"crossref","DOI":"10.1111\/add.13530","article-title":"Addiction classics","volume":"111","author":"Darke","year":"2016","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.drugpo.2017.06.005_bib0125","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/add.13429","article-title":"The toxicology of heroin-related death: Estimating survival times","volume":"111","author":"Darke","year":"2016","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.drugpo.2017.06.005_bib0130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0376-8716(98)00159-8","article-title":"Fluctuations in heroin purity and the incidence of fatal heroin overdose","volume":"54","author":"Darke","year":"1999","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.drugpo.2017.06.005_bib0135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMsa1406143","article-title":"Trends in opioid analgesic abuse and mortality in the United States","volume":"372","author":"Dart","year":"2015","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.drugpo.2017.06.005_bib0140","unstructured":"Data brief: opioid-related overdose deaths among Massachusetts residents. (2016). Retrieved from: http:\/\/www.mass.gov\/eohhs\/docs\/dph\/stop-addiction\/current-statistics\/data-brief-overdose-deaths-nov-2016-ma-residents.pdf (Accessed 13 February 2017)."},{"issue":"10","key":"10.1016\/j.drugpo.2017.06.005_bib0145","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/acem.12485","article-title":"Emergency medical services naloxone access: A national systematic legal review","volume":"21","author":"Davis","year":"2014","journal-title":"Academic Emergency Medicine"},{"key":"10.1016\/j.drugpo.2017.06.005_bib0150","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.drugalcdep.2015.02.010","article-title":"Abrupt decline in oxycodone-caused mortality after implementation of Florida's Prescription Drug Monitoring Program","volume":"150","author":"Delcher","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"7291","key":"10.1016\/j.drugpo.2017.06.005_bib0155","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/bmj.322.7291.895","article-title":"Take home naloxone and the prevention of deaths from opiate overdose: Two pilot schemes","volume":"322","author":"Dettmer","year":"2001","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.drugpo.2017.06.005_bib0160","doi-asserted-by":"crossref","first-page":"788","DOI":"10.2105\/AJPH.2008.146647","article-title":"Saved by the nose: Bystander-administered intranasal naloxone hydrochloride for opioid overdose","volume":"99","author":"Doe-Simkins","year":"2009","journal-title":"American Journal of Public Health"},{"issue":"1","key":"10.1016\/j.drugpo.2017.06.005_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recommendations and Reports"},{"key":"10.1016\/j.drugpo.2017.06.005_bib0170","unstructured":"Drug Checking Day. (2017)."},{"key":"10.1016\/j.drugpo.2017.06.005_bib0175","unstructured":"EcstasyData. (2017)."},{"issue":"3 Suppl","key":"10.1016\/j.drugpo.2017.06.005_bib0180","doi-asserted-by":"crossref","first-page":"ES191","DOI":"10.36076\/ppj.2012\/15\/ES191","article-title":"Prescription opioid related misuse, harms, diversion and interventions in Canada: A review","volume":"15","author":"Fischer","year":"2012","journal-title":"Pain Physician Journal"},{"key":"10.1016\/j.drugpo.2017.06.005_bib0185","article-title":"Providing a safe space and medical monitoring to prevent overdose deaths","author":"Gaeta","year":"2016","journal-title":"Health Affairs Blog"},{"issue":"10","key":"10.1016\/j.drugpo.2017.06.005_bib0190","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jamainternmed.2016.4310","article-title":"Counterfeit medications and fentanyl","volume":"176","author":"Green","year":"2016","journal-title":"JAMA Internal Medicine"},{"issue":"6","key":"10.1016\/j.drugpo.2017.06.005_bib0195","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1360-0443.2008.02182.x","article-title":"Distinguishing signs of opioid overdose and indication for naloxone: An evaluation of six overdose training and naloxone distribution programs in the United States","volume":"103","author":"Green","year":"2008","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.drugpo.2017.06.005_bib0200","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1526-4637.2011.01136.x","article-title":"Revisiting Paulozzi et al.'s prescription drug monitoring programs and death rates from drug overdose","volume":"12","author":"Green","year":"2011","journal-title":"Pain Medicine"},{"issue":"2","key":"10.1016\/j.drugpo.2017.06.005_bib0205","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1520\/JFS13045J","article-title":"Fentanyl-related deaths: Demographics, circumstances, and toxicology of 112 cases","volume":"36","author":"Henderson","year":"1991","journal-title":"Journal of Forensic Sciences"},{"key":"10.1016\/j.drugpo.2017.06.005_bib0210","unstructured":"HHS takes strong steps to address opioid-drug related overdose, death and dependence. (March 26, 2015). [Press release]. Retrieved from: https:\/\/www.hhs.gov\/about\/news\/2015\/03\/26\/hhs-takes-strong-steps-to-address-opioid-drug-related-overdose-death-and-dependence.html (Accessed 5 March 2017)"},{"key":"10.1016\/j.drugpo.2017.06.005_bib0215","unstructured":"Hospitalizations and Emergency Department Visits Due to Opioid Poisoning in Canada. (2016). Retrieved from Ottawa, ON."},{"key":"10.1016\/j.drugpo.2017.06.005_bib0220","unstructured":"Illicit Drug Overdose Deaths in BC January 1, 2007\u2013October 31, 2016. (2016). Retrieved from."},{"key":"10.1016\/j.drugpo.2017.06.005_bib0225","unstructured":"Illicit Drug Overdose Deaths in BC, January 1, 2007\u2013December 31, 2016. (2016). Retrieved from Burnaby, BC"},{"issue":"4","key":"10.1016\/j.drugpo.2017.06.005_bib0230","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2105\/AJPH.2016.303062","article-title":"Increase in naloxone prescriptions dispensed in US retail pharmacies since 2013","volume":"106","author":"Jones","year":"2016","journal-title":"American Journal of Public Health"},{"issue":"2","key":"10.1016\/j.drugpo.2017.06.005_bib0235","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2105\/AJPH.2015.302953","article-title":"Opioid overdose deaths and Florida's crackdown on pill mills","volume":"106","author":"Kennedy-Hendricks","year":"2016","journal-title":"American Journal of Public Health"},{"issue":"37","key":"10.1016\/j.drugpo.2017.06.005_bib0240","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.15585\/mmwr.mm6537a6","article-title":"Notes from the field: Furanyl-Fentanyl overdose events caused by smoking contaminated crack cocaine\u2014British Columbia, Canada, July 15\u201318, 2016","volume":"65","author":"Klar","year":"2016","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.drugpo.2017.06.005_bib0245","unstructured":"Lab test confirms carfentanil is being ingested. (2017). [Press release]. Retrieved from: https:\/\/news.gov.bc.ca\/releases\/2017HLTH0020-000224 (Accessed 9 February 2017)."},{"issue":"6","key":"10.1016\/j.drugpo.2017.06.005_bib0250","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/jamainternmed.2015.0914","article-title":"Rates of opioid dispensing and overdose after introduction of abuse-deterrent extended-release oxycodone and withdrawal of propoxyphene","volume":"175","author":"Larochelle","year":"2015","journal-title":"JAMA Internal Medicine"},{"issue":"18 Suppl. 2","key":"10.1016\/j.drugpo.2017.06.005_bib0255","doi-asserted-by":"crossref","first-page":"S501","DOI":"10.1161\/CIR.0000000000000264","article-title":"Part 10: Special circumstances of resuscitation: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care","volume":"132","author":"Lavonas","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.drugpo.2017.06.005_bib0260","unstructured":"Lurie, P. (2016). FDA\u2019s Naloxone App Prize Competition Celebrates Innovation In Search of Technological Solutions to the Opioid Epidemic. Retrieved from: http:\/\/blogs.fda.gov\/fdavoice\/index.php\/2016\/12\/fdas-naloxone-app-prize-competition-celebrates-innovation-in-search-of-technological-solutions-to-the-opioid-epidemic\/ (Accessed 9 February 2017)."},{"key":"10.1016\/j.drugpo.2017.06.005_bib0265","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.addbeh.2017.01.014","article-title":"Prevalence and correlates of fentanyl-contaminated heroin exposure among young adults who use prescription opioids non-medically","volume":"68","author":"Macmadu","year":"2017","journal-title":"Addictive Behaviors"},{"issue":"2","key":"10.1016\/j.drugpo.2017.06.005_bib0270","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drugpo.2013.10.004","article-title":"Every \u2018never\u2019 I ever said came true: Transitions from opioid pills to heroin injecting","volume":"25","author":"Mars","year":"2014","journal-title":"International Journal of Drug Policy"},{"issue":"9775","key":"10.1016\/j.drugpo.2017.06.005_bib0275","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(10)62353-7","article-title":"Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: A retrospective population-based study","volume":"377","author":"Marshall","year":"2011","journal-title":"The Lancet"},{"issue":"2","key":"10.1016\/j.drugpo.2017.06.005_bib0280","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0196-0644(05)81216-8","article-title":"China White epidemic: An eastern United States emergency department experience","volume":"20","author":"Martin","year":"1991","journal-title":"Annals of Emergency Medicine"},{"issue":"3","key":"10.1016\/j.drugpo.2017.06.005_bib0285","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1300\/J069v25n03_11","article-title":"Prescribing naloxone to actively injecting heroin users: A program to reduce heroin overdose deaths","volume":"25","author":"Maxwell","year":"2006","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.drugpo.2017.06.005_bib0290","series-title":"Drugs tested at insite, 86% contain fentanyl","author":"Mcelroy","year":"2016"},{"key":"10.1016\/j.drugpo.2017.06.005_bib0295","unstructured":"The Mobile Monitoring of Vital Signs in Opioid Users (MOVE). (2015) Retrieved from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02647073 (Accessed 9 February 2017)."},{"issue":"1\u20132","key":"10.1016\/j.drugpo.2017.06.005_bib0300","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.drugalcdep.2013.01.006","article-title":"Relationship of opioid prescription sales and overdoses, North Carolina","volume":"132","author":"Modarai","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.drugpo.2017.06.005_bib0305","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1520\/JFS10410J","article-title":"Some observations concerning blood morphine concentrations in narcotic addicts","volume":"22","author":"Monforte","year":"1977","journal-title":"Journal of Forensic Science"},{"issue":"4","key":"10.1016\/j.drugpo.2017.06.005_bib0310","first-page":"E605","article-title":"Prescription opioid use, harms and interventions in Canada: A review update of new developments and findings since 2010","volume":"18","author":"Murphy","year":"2015","journal-title":"Pain Physician"},{"issue":"10","key":"10.1016\/j.drugpo.2017.06.005_bib0315","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/add.13027","article-title":"Naloxone\u2013does over-antagonism matter? Evidence of iatrogenic harm after emergency treatment of heroin\/opioid overdose","volume":"110","author":"Neale","year":"2015","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.drugpo.2017.06.005_bib0320","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/08897077.2015.1129528","article-title":"Patient perspectives on an opioid overdose education and naloxone distribution program in the U.S. Department of Veterans Affairs","volume":"37","author":"Oliva","year":"2016","journal-title":"Substance Abuse"},{"issue":"3","key":"10.1016\/j.drugpo.2017.06.005_bib0325","doi-asserted-by":"crossref","first-page":"E153","DOI":"10.9778\/cmajo.20140008","article-title":"A quantitative and qualitative evaluation of the British Columbia Take Home Naloxone program","volume":"2","author":"Oluwajenyo Banjo","year":"2014","journal-title":"CMAJ Open"},{"issue":"8","key":"10.1016\/j.drugpo.2017.06.005_bib0330","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa0810635","article-title":"Diacetylmorphine versus methadone for the treatment of opioid addiction","volume":"361","author":"Oviedo-Joekes","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1016\/j.drugpo.2017.06.005_bib0335","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/jamapsychiatry.2016.0109","article-title":"Hydromorphone compared with diacetylmorphine for long-term opioid dependence: A randomized clinical trial","volume":"73","author":"Oviedo-Joekes","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.drugpo.2017.06.005_bib0340","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1526-4637.2011.01062.x","article-title":"Prescription drug monitoring programs and death rates from drug overdose","volume":"12","author":"Paulozzi","year":"2011","journal-title":"Pain Medicine"},{"issue":"33","key":"10.1016\/j.drugpo.2017.06.005_bib0345","doi-asserted-by":"crossref","first-page":"844","DOI":"10.15585\/mmwr.mm6533a3","article-title":"Increases in fentanyl-related overdose deaths\u2014Florida and Ohio, 2013\u20132015","volume":"65","author":"Peterson","year":"2016","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"4","key":"10.1016\/j.drugpo.2017.06.005_bib0350","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.amepre.2010.05.016","article-title":"Increase in unintentional medication overdose deaths: Oklahoma, 1994\u20132006","volume":"39","author":"Piercefield","year":"2010","journal-title":"American Journal of Preventive Medicine"},{"issue":"50-51","key":"10.1016\/j.drugpo.2017.06.005_bib0355","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths\u2014United States, 2000\u20132014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"5051","key":"10.1016\/j.drugpo.2017.06.005_bib0360","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths\u2014United States, 2010\u20132015","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"10","key":"10.1016\/j.drugpo.2017.06.005_bib0365","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1001\/jamainternmed.2015.3931","article-title":"Effect of Florida's prescription drug monitoring program and Pill Mill Laws on opioid prescribing and use","volume":"175","author":"Rutkow","year":"2015","journal-title":"JAMA Internal Medicine"},{"issue":"10","key":"10.1016\/j.drugpo.2017.06.005_bib0370","first-page":"38","article-title":"Emergency department naloxone distribution: a Rhode Island department of health, recovery community, and emergency department partnership to reduce opioid overdose deaths","volume":"97","author":"Samuels","year":"2014","journal-title":"Rhode Island Medical Journal (2013)"},{"key":"10.1016\/j.drugpo.2017.06.005_bib0375","unstructured":"San Francisco Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2016. (2016). Retrieved from."},{"key":"10.1016\/j.drugpo.2017.06.005_bib0380","unstructured":"SBIR Phase I\u2014Automated Naloxone Delivery System. (2012)."},{"issue":"5","key":"10.1016\/j.drugpo.2017.06.005_bib0385","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2105\/AJPH.2012.301049","article-title":"Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995\u20132009","volume":"103","author":"Schwartz","year":"2013","journal-title":"American Journal of Public Health"},{"issue":"2","key":"10.1016\/j.drugpo.2017.06.005_bib0390","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/jurban\/jtg032","article-title":"Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: A survey of street-recruited injectors in the San Francisco Bay Area","volume":"80","author":"Seal","year":"2003","journal-title":"Journal of Urban Health"},{"issue":"2","key":"10.1016\/j.drugpo.2017.06.005_bib0395","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jurban\/jti053","article-title":"Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: A pilot intervention study","volume":"82","author":"Seal","year":"2005","journal-title":"Journal of Urban Health"},{"issue":"2S","key":"10.1016\/j.drugpo.2017.06.005_bib0400","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.japh.2016.12.075","article-title":"A nationwide pharmacy chain responds to the opioid epidemic","volume":"57","author":"Shafer","year":"2017","journal-title":"Journal of American Pharmacists Association (2003)"},{"issue":"1","key":"10.1016\/j.drugpo.2017.06.005_bib0405","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1360-0443.2007.02054.x","article-title":"Unintentional drug overdose death trends in New Mexico, USA, 1990\u20132005: Combinations of heroin, cocaine, prescription opioids and alcohol","volume":"103","author":"Shah","year":"2008","journal-title":"Addiction"},{"issue":"14","key":"10.1016\/j.drugpo.2017.06.005_bib0410","doi-asserted-by":"crossref","first-page":"382","DOI":"10.15585\/mmwr.mm6614a2","article-title":"Characteristics of fentanyl overdose\u2014Massachusetts, 2014\u20132016","volume":"66","author":"Somerville","year":"2017","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.drugpo.2017.06.005_bib0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.japh.2016.12.077","article-title":"Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015","author":"Stopka","year":"2017","journal-title":"J Am Pharm Assoc (2003)."},{"issue":"1","key":"10.1016\/j.drugpo.2017.06.005_bib0420","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/acem.13034","article-title":"Fatal fentanyl: One pill can kill","volume":"24","author":"Sutter","year":"2017","journal-title":"Academic Emergency Medicine"},{"key":"10.1016\/j.drugpo.2017.06.005_bib0425","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2016.11.033","article-title":"A review: Fentanyl and non-pharmaceutical fentanyls","volume":"171","author":"Suzuki","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.drugpo.2017.06.005_bib0430","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.drugpo.2008.03.002","article-title":"Evaluation of the Staying Alive programme: Training injection drug users to properly administer naloxone and save lives","volume":"20","author":"Tobin","year":"2009","journal-title":"International Journal of Drug Policy"},{"issue":"4","key":"10.1016\/j.drugpo.2017.06.005_bib0435","doi-asserted-by":"crossref","first-page":"107","DOI":"10.15585\/mm6604a4","article-title":"Multiple fentanyl overdoses \u2013 New Haven, Connecticut, June 23, 2016","volume":"66","author":"Tomassoni","year":"2017","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"2 Suppl","key":"10.1016\/j.drugpo.2017.06.005_bib0440","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.36076\/ppj.2008\/11\/S133","article-title":"Opioid pharmacology","volume":"11","author":"Trescot","year":"2008","journal-title":"Pain Physician"},{"issue":"2","key":"10.1016\/j.drugpo.2017.06.005_bib0445","article-title":"Intertwined epidemics: National demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993\u20132009","volume":"8","author":"Unick","year":"2013","journal-title":"Public Library of Science"},{"issue":"4","key":"10.1016\/j.drugpo.2017.06.005_bib0450","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s11524-015-9967-y","article-title":"Opioid overdose deaths in the city and county of San Francisco: Prevalence, distribution, and disparities","volume":"92","author":"Visconti","year":"2015","journal-title":"Journal of Urban Health"},{"issue":"1","key":"10.1016\/j.drugpo.2017.06.005_bib0455","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.drugpo.2013.07.003","article-title":"I felt like a superhero: The experience of responding to drug overdose among individuals trained in overdose prevention","volume":"25","author":"Wagner","year":"2014","journal-title":"International Journal of Drug Policy"},{"issue":"3","key":"10.1016\/j.drugpo.2017.06.005_bib0460","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.drugpo.2009.01.003","article-title":"Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA","volume":"21","author":"Wagner","year":"2010","journal-title":"International Journal of Drug Policy"},{"issue":"2","key":"10.1016\/j.drugpo.2017.06.005_bib0465","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jsat.2012.07.004","article-title":"Opioid overdose prevention with intranasal naloxone among people who take methadone","volume":"44","author":"Walley","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.drugpo.2017.06.005_bib0470","doi-asserted-by":"crossref","first-page":"f174","DOI":"10.1136\/bmj.f174","article-title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis","volume":"346","author":"Walley","year":"2013","journal-title":"British Medical Journal"},{"issue":"23","key":"10.1016\/j.drugpo.2017.06.005_bib0475","first-page":"631","article-title":"Opioid Overdose Prevention Programs Providing Naloxone to Laypersons ? United States, 2014","volume":"64","author":"Wheeler","year":"2015","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.drugpo.2017.06.005_bib0480","unstructured":"Wilkins, L., Formica, S. W., Ruiz, S., Reilly, B., Apsler, R., & Walley, A. Y. (2016). Post-Opioid Overdose Follow-up Programs by Police and Fire Departments in Massachusetts [abstract Supp 1]. In: Gordon, A. The 40th Annual Meeting of AMERSA \u2212 Highlights, Abstracts and Awards. Substance Abuse, 38(1)."},{"key":"10.1016\/j.drugpo.2017.06.005_bib0485","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.drugpo.2016.08.014","article-title":"Drug use in business bathrooms: An exploratory study of manager encounters in New York City","volume":"39","author":"Wolfson-Stofko","year":"2017","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2017.06.005_bib0490","series-title":"Mobile Medical Unit brings hope, relief to B.C. overdose victims","author":"Woo","year":"2017"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917301688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917301688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T12:55:12Z","timestamp":1659185712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395917301688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":98,"alternative-id":["S0955395917301688"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.06.005","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}